Measuring the Impact of the COVID-19 Pandemic on Diagnostic Delay in Rare Disease

 Journals and Articles / by Jo McPherson / 23 views

Rare diseases are individually rare but collectively common, with a combined prevalence of 3.5–5.9%. A common feature of many diseases is a substantial delay in patients receiving a correct diagnosis; this protracted path to diagnosis is termed ‘the diagnostic odyssey’. During the COVID-19 pandemic, significant concerns have emerged from both clinicians and patients regarding a disproportionate effect of the pandemic on diagnosis and management of rare disease. Such concerns prompted a study to explore this question further, the results of which are presented here:

https://www.emjreviews.com/innovations/article/measuring-the-impact-of-the-covid-19-pandemic-on-diagnostic-delay-in-rare-disease/

  • Listing ID: 9957
Contact details